Atrium Therapeutics Inc (RNA)

Investing Cash Flow

-$191.59M

Quarterly · Period ending: · USD

RNA logo

RNA Investing Cash Flow

Latest reported-$191.59M
RNA Quarterly Cash from Investing (-$879.00K → -$191.59M)
High-resolution chart · PNG

RNA investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-191,587,000
-2,098,000
-879,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.